Ronald Ifraimov

FDA investigator

Appears on 10 documents from 2014 to 2026, mostly at sites in Florida. Most often cites design controls (21 CFR 820.30(b)).

10
Documents on file
2.5
Observations per 483
2014
First seen
2026
Most recent

What they cite most

From 25 observations

Activity by year

2014: 1, 2015: 1, 2016: 1, 2019: 1, 2023: 3, 2024: 1, 2026: 2

Where

Florida 6 · New York 3 · Ireland 1

Often inspects with

Colin E. Tack· Andrew Garufi

Is Ronald Ifraimov coming to your site?

Our team writes custom reports before an inspection: what this investigator cites most, how they write it up, and how your site's history compares, in one brief you can circulate.

Ask about any investigator in Claude or ChatGPT with the AI connector.

Inspection history

10 documents, newest first
FirmOpen
483 Dharma Research, IncMar 13, 2026 · Miami, Florida
483 BioTissue Holdings IncFeb 18, 2026 · Doral, Florida
483 Dharma Research, Inc.Dec 11, 2024 · Miami, Florida
483 American Medical Endoscopy, IncOct 11, 2023 · Doral, Florida
483 Pure Source, LLCAug 31, 2023 · Doral, Florida
483 USpharma LtdMay 11, 2023 · Miami Lake, Florida
483 Respire Medical Holdings, LLCAug 15, 2019 · Brooklyn, New York

About this profile

What does Ronald Ifraimov inspect?

Ronald Ifraimov appears on 10 documents on file covering 9 sites, mostly in Florida.

What do they cite most often?

21 CFR 820.30(b) (design controls), followed by 21 CFR 803.50(a)(1) and 21 CFR 820.100(b).

Can I read the observations?

Each document page previews the opening words of every observation. The full documents are available to buy, one at a time or together.

How current is this profile?

The most recent document on file for Ronald Ifraimov is dated Mar 13, 2026.